Drug Profile
Research programme: neurological disorders therapeutics - Prevacus
Alternative Names: Synthetic neurosteroids - PrevacusLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Prevacus
- Class Neuroprotectants; Sterols
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Brain injuries; Neurological disorders
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for preclinical development in Brain injuries in USA (Intranasal)
- 28 Sep 2021 No recent reports of development identified for preclinical development in Neurological-disorders in USA (Intranasal)
- 09 Sep 2019 Preclinical development is ongoing in Brain injuries and Neurological disorders in USA